Cargando…
Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high mortality rates. PDAC initiation and progression are promoted by genetic and epigenetic dysregulation. Here, we aimed to characterize the PDAC DNA methylome in search of novel altered pathways associated with tumor developmen...
Autores principales: | Gregório, Cleandra, Soares-Lima, Sheila Coelho, Alemar, Bárbara, Recamonde-Mendoza, Mariana, Camuzi, Diego, de Souza-Santos, Paulo Thiago, Rivero, Raquel, Machado, Simone, Osvaldt, Alessandro, Ashton-Prolla, Patricia, Pinto, Luis Felipe Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407273/ https://www.ncbi.nlm.nih.gov/pubmed/32629766 http://dx.doi.org/10.3390/cancers12071735 |
Ejemplares similares
-
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review
por: Alemar, Bárbara, et al.
Publicado: (2015) -
Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis
por: Camuzi, Diego, et al.
Publicado: (2021) -
Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1
por: Gregório, Cleandra, et al.
Publicado: (2020) -
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
por: Camuzi, Diego, et al.
Publicado: (2019) -
TULP3: A potential biomarker in colorectal cancer?
por: Sartor, Ivaine Taís Sauthier, et al.
Publicado: (2019)